Elevance Health, Inc. (NYSE:ELV) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC lessened its holdings in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 0.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 386,404 shares of the company's stock after selling 1,731 shares during the quarter. Janus Henderson Group PLC owned about 0.17% of Elevance Health worth $200,928,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Iridian Asset Management LLC CT boosted its position in shares of Elevance Health by 10.7% during the 3rd quarter. Iridian Asset Management LLC CT now owns 39,154 shares of the company's stock valued at $20,360,000 after acquiring an additional 3,786 shares during the last quarter. International Assets Investment Management LLC increased its stake in Elevance Health by 85,533.1% in the 3rd quarter. International Assets Investment Management LLC now owns 532,638 shares of the company's stock worth $276,972,000 after purchasing an additional 532,016 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its stake in Elevance Health by 5.0% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 209,859 shares of the company's stock worth $109,127,000 after purchasing an additional 9,916 shares during the period. Seizert Capital Partners LLC increased its stake in shares of Elevance Health by 26.3% during the third quarter. Seizert Capital Partners LLC now owns 104,229 shares of the company's stock valued at $54,199,000 after buying an additional 21,708 shares during the period. Finally, Mizuho Securities USA LLC increased its stake in shares of Elevance Health by 185.4% during the third quarter. Mizuho Securities USA LLC now owns 51,153 shares of the company's stock valued at $26,600,000 after buying an additional 33,231 shares during the period. Institutional investors own 89.24% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ELV shares. Wells Fargo & Company reduced their target price on Elevance Health from $593.00 to $495.00 and set an "overweight" rating on the stock in a research note on Monday, November 4th. Cantor Fitzgerald dropped their price objective on Elevance Health from $600.00 to $485.00 and set an "overweight" rating on the stock in a research report on Friday, October 18th. Argus cut Elevance Health from a "buy" rating to a "hold" rating in a research report on Friday, October 18th. Morgan Stanley dropped their price objective on Elevance Health from $643.00 to $551.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 23rd. Finally, TD Cowen dropped their price objective on Elevance Health from $589.00 to $484.00 and set a "buy" rating on the stock in a research report on Monday, October 21st. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $539.20.

Insider Transactions at Elevance Health

In other Elevance Health news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of the stock in a transaction that occurred on Friday, October 18th. The stock was sold at an average price of $432.14, for a total transaction of $3,205,182.38. Following the completion of the transaction, the executive vice president now owns 8,423 shares of the company's stock, valued at $3,639,915.22. This represents a 46.82 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.35% of the company's stock.

Elevance Health Stock Down 1.9 %

NYSE ELV traded down $7.88 on Wednesday, reaching $400.19. 1,903,523 shares of the stock traded hands, compared to its average volume of 1,194,388. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.50 and a current ratio of 1.50. The company has a fifty day moving average price of $439.60 and a 200-day moving average price of $501.50. The company has a market cap of $92.81 billion, a price-to-earnings ratio of 14.59, a PEG ratio of 1.22 and a beta of 0.83. Elevance Health, Inc. has a 12 month low of $391.02 and a 12 month high of $567.26.

Elevance Health (NYSE:ELV - Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The company reported $8.37 EPS for the quarter, missing the consensus estimate of $9.66 by ($1.29). Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The company had revenue of $44.72 billion during the quarter, compared to the consensus estimate of $43.47 billion. During the same period in the previous year, the firm posted $8.99 earnings per share. The company's revenue was up 5.3% on a year-over-year basis. As a group, research analysts forecast that Elevance Health, Inc. will post 32.96 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Thursday, December 5th will be paid a $1.63 dividend. The ex-dividend date is Thursday, December 5th. This represents a $6.52 dividend on an annualized basis and a dividend yield of 1.63%. Elevance Health's payout ratio is 23.77%.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.